X-Chem

Glamorous AI develops an artificial intelligence driven drug discovery platform that accelerates pharmaceutical research by leveraging prior experimental results to identify and optimize chemical scaffolds, predict activities, and screen ultra-large chemical libraries. The platform addresses low-data, sparse, and noisy datasets, enabling the discovery of novel compounds and potential therapeutics.

ComInnex is a global provider of synthetic chemistry services and novel chemical technologies, supporting early-stage drug discovery for pharmaceutical companies, biotech startups, academic institutions, and government agencies worldwide. The company offers small molecule design, chemical library development and synthesis, project management, and customer service, prioritizing open communication, quick reaction times, and confidentiality to meet clients' needs efficiently.

IntelliSyn providers of medicinal chemistry support in North America. Our team of experienced scientists (>80% PhD), at our state-of-the-art facilities in Montreal, specializes in identifying novel leads and optimizing them as successful clinical candidates for our collaborators across Major Pharma and Biotech. IntelliSyn provide discovery support (computational chemistry, design, synthesis, and DMPK) where innovation, intellectual property security, and proven delivery-expertise are needed on an expert basis. Our discipline expertise ranges across CNS, oncology, metabolic diseases as well as other specialized areas including structure-based design, GPCR modulators, and ion channel modulators.